Last Updated : March 8, 2023
Details
FilesProject Status:
Complete
Therapeutic Area:
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0018-000
Review Type: Panel
Provisional Funding Algorithm |
|
|---|---|
|
Stakeholder Input Deadline: |
December 8, 2022 |
|
Draft Report Posted: |
January 26, 2023 |
|
Stakeholder Feedback Deadline: |
February 2, 2023 |
|
Final Report Posted: |
March 8, 2023 |
Files
Last Updated : March 8, 2023